130 related articles for article (PubMed ID: 38373702)
21. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.
Liu S; Tang W; Zhou J; Stubbs JR; Luo Q; Pi M; Quarles LD
J Am Soc Nephrol; 2006 May; 17(5):1305-15. PubMed ID: 16597685
[TBL] [Abstract][Full Text] [Related]
22. Phosphate-sensing and regulatory mechanism of FGF23 production.
Takashi Y; Fukumoto S
J Endocrinol Invest; 2020 Jul; 43(7):877-883. PubMed ID: 32140858
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K
Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240
[TBL] [Abstract][Full Text] [Related]
24. Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions.
Agoro R; White KE
Nat Rev Nephrol; 2023 Mar; 19(3):185-193. PubMed ID: 36624273
[TBL] [Abstract][Full Text] [Related]
25. In vitro regulation of fibroblast growth factor 23 by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D synthesized by osteocyte-like MC3T3-E1 cells.
Ratsma DMA; Muller M; Koedam M; Zillikens MC; van der Eerden BCJ
Eur J Endocrinol; 2023 Oct; 189(4):448-459. PubMed ID: 37796032
[TBL] [Abstract][Full Text] [Related]
26. Calcineurin inhibitors regulate fibroblast growth factor 23 (FGF23) synthesis.
Bär L; Großmann C; Gekle M; Föller M
Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1117-1123. PubMed ID: 28761977
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
[TBL] [Abstract][Full Text] [Related]
28. 1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes.
Orfanidou T; Malizos KN; Varitimidis S; Tsezou A
Exp Biol Med (Maywood); 2012 Mar; 237(3):241-53. PubMed ID: 22393163
[TBL] [Abstract][Full Text] [Related]
29. NFκB-sensitive Orai1 expression in the regulation of FGF23 release.
Zhang B; Yan J; Umbach AT; Fakhri H; Fajol A; Schmidt S; Salker MS; Chen H; Alexander D; Spichtig D; Daryadel A; Wagner CA; Föller M; Lang F
J Mol Med (Berl); 2016 May; 94(5):557-66. PubMed ID: 26631141
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
31. Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling.
Egli-Spichtig D; Zhang MYH; Li A; Pastor Arroyo EM; Hernando N; Wagner CA; Chang W; Perwad F
Sci Rep; 2021 Mar; 11(1):6175. PubMed ID: 33731726
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.
Shimada T; Yamazaki Y; Takahashi M; Hasegawa H; Urakawa I; Oshima T; Ono K; Kakitani M; Tomizuka K; Fujita T; Fukumoto S; Yamashita T
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1088-95. PubMed ID: 15998839
[TBL] [Abstract][Full Text] [Related]
33. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
Liu S; Gupta A; Quarles LD
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo.
Küng CJ; Haykir B; Schnitzbauer U; Egli-Spichtig D; Hernando N; Wagner CA
Am J Physiol Renal Physiol; 2021 Dec; 321(6):F785-F798. PubMed ID: 34719948
[TBL] [Abstract][Full Text] [Related]
35. Regulation of fibroblast growth factor 23 production in bone in uremic rats.
Saji F; Shiizaki K; Shimada S; Okada T; Kunimoto K; Sakaguchi T; Hatamura I; Shigematsu T
Nephron Physiol; 2009; 111(4):p59-66. PubMed ID: 19339809
[TBL] [Abstract][Full Text] [Related]
36. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Andrukhova O; Streicher C; Zeitz U; Erben RG
Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor 23 inhibits osteogenic differentiation and mineralization of chicken bone marrow mesenchymal stem cells.
Lyu Z; Li H; Li X; Wang H; Jiao H; Wang X; Zhao J; Lin H
Poult Sci; 2023 Jan; 102(1):102287. PubMed ID: 36442309
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast Growth Factor 23 Bone Regulation and Downstream Hormonal Activity.
Clinkenbeard E
Calcif Tissue Int; 2023 Jul; 113(1):4-20. PubMed ID: 37306735
[TBL] [Abstract][Full Text] [Related]
39. Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.
Martin A; Quarles LD
Adv Exp Med Biol; 2012; 728():65-83. PubMed ID: 22396162
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
